Successful Innovation in B2B Takes Bringing the Whole Company to the Table

Paragon Innovations Banner Ad

 

In the realm of business, the term ‘innovation’ is often tossed around like a shiny buzzword, suggesting a world of limitless possibilities and creative experimentation. Especially when tackling innovation in B2B, though, whether in the form of new business models, products, services, or partnerships, true innovation requires far more than mere brainstorming and ideation; it demands a disciplined and strategic approach to transform ideas into tangible, profitable outcomes.

Innovation in B2B takes many forms. In healthcare, digital innovation is creating new competitive edges for medtech and solutions providers as digital payments and AI sweep the industry. Digital transformation is also opening new doors in B2B; companies across industry are seeing value with innovation in B2B that makes embedded analytics a strategic priority and a transformation agent for operations, new services, financial efficacy, and more. Some thought leaders put the emphasis on media strategies being the chief battleground for innovation as B2B works to catch up to B2C and adopt innovative digital marketing strategies.

What really makes for a successful strategy for innovation in B2B, though? Regardless of the market or technology in question, organizational culture that fosters unedited and free-flowing ideas, yet couples this creativity with rigorous mechanisms to ensure these ideas are more than just fleeting thoughts, is the bedrock of any successful mission of innovation in B2B companies. Gerry Mecca, a cutting-edge senior leader in technology and Principal at The EKG Group, shares some of his strategies for making good on promises of innovation, pulling from his 40+ years working in the technology and CPG sectors and consulting businesses on their executive technology strategies.

“I always think of the example of penicillin was invented somewhat accidentally, then innovated once so that it could be taken on to the field in military applications. But the real innovation was when it was made into a pill that people could take. Each of those steps were innovations,” Mecca said. “None of those steps would have taken place if somebody didn’t sit down and say, here’s what we could do or what do you think about this? Get a bunch of smart people together, get them to have a little bit of money to make their innovations become more than just a piece of paper.”

Article written by Daniel Litwin.

Follow us on social media for the latest updates in B2B!

Image

Latest

Doable
Rethinking Leadership: Why “Doable” Might Be the Most Powerful Strategy in Education Today
April 3, 2026

At a time when educator burnout is rising and schools across the U.S. are facing ongoing teacher shortages, leaders are being forced to rethink what sustainable success actually looks like. Research shows that teacher attrition is closely tied to working conditions, job-related stress, and workload demands. As districts push for innovation, data-driven instruction, and…

Read More
Casey Brown
From Poverty to Pricing Power | Why Great Companies Undercharge
April 2, 2026

Casey Brown didn’t grow up thinking she would become an entrepreneur. She grew up in a blue-collar family where money was always tight — close enough to the edge that the fear of poverty shaped many of her early decisions. That fear led her into engineering, into corporate America, and eventually into a moment…

Read More
Nightingales Summit: Empowering the Next Generation of Nigerian Nurses
Nightingales Summit: Empowering the Next Generation of Nigerian Nurses
April 2, 2026

In this episode of Care Anywhere, host Lea Sims sits down with Nigerian nurse entrepreneur and advocate Obafemi Arowosegbe to discuss leadership, mentorship, and the future of nursing in Africa. While still a nursing student, Obafemi founded the Nightingale Summit, a growing conference designed to empower nursing students and early-career nurses with leadership skills,…

Read More
Oncology
From Denial to Access: Rethinking Oncology Care Through AI, Clinical Trials, and Patient-Centered Innovation
April 1, 2026

The rapid expansion of precision medicine, biologics, and targeted cancer therapies is transforming oncology—but it’s also overwhelming a system not built to keep pace. In the U.S., cancer drugs now account for some of the highest-cost treatments in healthcare, and with that has come a surge in prior authorization requirements and denials. Studies suggest physicians…

Read More